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Abstract 
Background: Despite declining prevalence of malaria in The Gambia, non-adherence to anti-malarial treatment still 
remains a challenge to control efforts. There is limited evidence on the socio-cultural factors that influence adherence 
to anti-malarial treatment in pregnancy. This study explored perceptions of malaria in pregnancy and their influence 
on adherence to anti-malarial treatment in a rural area of The Gambia.
Methods: An exploratory ethnographic study was conducted ancillary to a cluster-randomized trial on scheduled 
screening and treatment of malaria in pregnancy at village level in the Upper River Region of The Gambia from June 
to August 2014. Qualitative data were collected through interviewing and participant observation. Analysis was con-
current to data collection and carried out using NVivo 10.
Results: Although women had good bio-medical knowledge of malaria in pregnancy, adherence to anti-malarial 
treatment was generally perceived to be low. Pregnant women were perceived to discontinue the provided anti-
malarial treatment after one or 2 days mainly due to non-recognition of symptoms, perceived ineffectiveness of the 
anti-malarial treatment, the perceived risks of medication and advice received from mothers-in-law.
Conclusion: Improving women’s knowledge of malaria in pregnancy is not sufficient to assure adherence to anti-
malarial treatment. Addressing structural barriers such as unclear health workers’ messages about medication dosage, 
illness recognition, side effects of the medication and the integration of relatives, especially the mothers-in-law, in 
community-based programmes are additionally required.
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Background
In malaria endemic countries, pregnant women are par-
ticularly vulnerable to malaria infection and its conse-
quences because of physiological hormonal changes, 
reduced immunity, social vulnerability and diffi-
culty in accessing health care [1–3]. Symptomatic and 
asymptomatic Plasmodium falciparum infections in 
pregnancy can cause adverse maternal health and poor 
birth outcomes, with higher risk in primigravidae (first 
pregnancy) due to a combination of biological and social 
factors including adolescent’s social position, social 
acknowledgment process of pregnancy and labor require-
ments in households [3]. For the control of malaria 
in pregnancy (MiP) in sub-Saharan Africa, the World 
Health Organization (WHO) currently recommends 
individual case management with anti-malarial drugs 
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based on the pregnancy stages, i.e., (i) quinine plus clin-
damycin in the first trimester and (ii)  artemisinin-based 
combination therapy (ACT) in the second and third tri-
mester [4]. Additionally, the WHO advises intermittent 
preventive treatment with sulfadoxine–pyrimethamine 
(IPTp-SP) during the second and third trimester, given at 
least 1 month apart, when women attend antenatal clin-
ics [4]. A proposed alternative strategy for MiP, especially 
in areas where SP resistance is high, is the systematic 
screening for malaria and consequent treatment of posi-
tive pregnant women [5]. For the success of these strate-
gies adherence is crucial. Poor adherence does not only 
increase the risk of recurrent infections but it may also 
select resistant parasite strains [6–8].
Research in malaria endemic countries has shown that 
the decision to adhere to anti-malarials is influenced by, 
practical reasoning and structural social factors such as, 
the perceived risks of the medication [3, 9–13] malaria-
related beliefs and interpretations of malaria as certain 
folk illnesses that may delay or stop treatment [12, 14, 
15]. Concerns for the safety of the mother and child, for 
example, when receiving medication late in pregnancy 
was an often-decisive factor for treatment adherence 
in Burkina Faso [3], while in Uganda and Malawi bitter 
medications such as quinine are commonly avoided dur-
ing pregnancy due to their perceived ability to cause mis-
carriage and stillbirth [16–18].
In The Gambia, the factors influencing adherence of 
pregnant women to anti-malarial treatment are largely 
unknown. Research on MiP to date has focused mainly 
on the uptake of intermittent preventive treatment with 
IPTp-SP [16] rather than on the investigation on the 
use of anti-malarials for case management. This study 
aimed to explore malaria-related illness perceptions dur-
ing pregnancy and their influence on adherence to anti-
malarial treatment within the socio-cultural context of 
rural Gambia.
Methods
Research design
The study consisted of exploratory ethnographic research 
ancillary to the cluster randomized trial “Community 
Based Scheduled Screening and Treatment of Malaria 
in Pregnancy for Improved Maternal and Infant Health” 
(referred to hereafter as the ‘COSMIC’ study) (Trial Reg-
istration: Current Controlled Trials ISRCTN37259296) 
[22]. The study focused on exploring general percep-
tions of adherence to treatment for MiP irrespective of 
diagnosis by RDTs given the low prevalence in the study 
area at the time of the study. Data were collected through 
qualitative research techniques, i.e., participant observa-
tion, informal conversations and semi-structured inter-
views. Data were triangulated in order to limit response 
bias and to form an in-depth understanding of pregnant 
women’s perceptions related to anti-malarial medication.
Study site and population
Study site
The study was conducted between June and August 
2014 in the eastern part of The Gambia (i.e., Upper River 
Region). The study villages were Demba Kunta Koto, 
Kuta and Mandinka, selected based on previously col-
lected epidemiological data within the COSMIC study 
(i.e., malaria incidence, indicators of access to antena-
tal care (ANC) and uptake of the intervention). Malaria 
transmission in The Gambia has decreased substantially 
over the last 10 years [19, 20], revealing increasing heter-
ogeneity, with the eastern part of the country having the 
highest prevalence [21]. Plasmodium falciparum is the 
main malaria species and transmission in the area is sea-
sonal, occurring primarily between July and December.
Study population
The population was mainly Serahule and Mandinka, 
and predominantly Muslim. The area is rural with most 
inhabitants practicing subsistence farming of groundnut 
and maize and small-scale informal trade. Remittances 
received from relatives that have migrated to urban parts 
of the country, elsewhere in Africa, Europe or USA con-
tributed to the livelihoods of some families.
Malaria treatment
Anti-malarial treatment in the area was provided at sat-
ellite health posts operated by community health nurses 
(CHNs) and at a major health centre situated 10  km 
away in Basse Sante Su (a regional level health cen-
tre). National guidelines for uncomplicated MiP is oral 
quinine, but artemisinin-based combination therapy 
(artemether-lumefantrine) may be used in the second 
and third trimesters. As this study was ancillary to the 
COSMIC study [22], in the intervention villages, village 
health workers (VHWs) followed a training programme 
in which the burden of MiP and its consequences, and 
the need for pregnant women to take IPTp-SP as early as 
possible in the second trimester were highlighted. VHWs 
were trained to use rapid diagnostic test (RDTs) and to 
treat positive cases with artemether-lumefantrine.
Data collection
Participant observation
Participant observation consisted of participating in eve-
ryday activities in the communities and observing ANC 
services and activities at the heath posts. These obser-
vations offered the opportunity for numerous reiterated 
conversations with community members. This facilitated 
trust between the researcher and study participants. 
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Additionally, the observations were important to over-
come the bias that is often inherent to self-reporting 
techniques.
Semi‑structured interviews
Interviews were recorded and fully transcribed. When 
not possible and/or inappropriate, the conversation was 
not recorded but its content was written down in a field 
diary.
Sampling
Sampling was theoretical, meaning participants were 
chosen purposively based on emerging results. Partici-
pants identified from the health posts and home visits 
were selected on criteria such as gender, age, parity, and 
social position. Furthermore, “snowball” sampling—sam-
pling using participants to identify additional respond-
ents—was utilized to facilitate participant’s confidence 
in the researcher and hence reduce response bias. The 
inclusion of other community members, such as health 
workers and traditional birth attendants, allowed a more 
holistic understanding of pregnant women’s adherence 
and reduced the effects of self-reporting bias when only 
including accounts of pregnant women (Table 1).
Data analysis
Data analysis was an iterative process. All observational 
findings were noted, compiled and analysed at the end 
of each day. Whilst still in the field, the researcher trans-
lated initial recorded interviews from the local language 
(Mandinka and Serahuli) into English. These transcripts 
and observational notes were sequentially analysed in 
order to inform the interview guide; participant observa-
tion and interviews were then conducted to confirm or 
refute temporary results until saturation was reached. 
Data were systemized and analysed with NVivo 10 Quali-
tative Analysis Software (QSR International Pty Ltd. Car-
digan UK). The PASS Malaria in Pregnancy Treatment 
model [12] and the PASS Health Seeking Behaviour model 
[23] were used to guide the analytic process. Quotations 
are presented in this paper to illustrate the range of per-
ceptions within each theme illustrating the respondent’s 
perspectives [24].
Ethical approval
Ethical clearance for this study was obtained from the 
Department of Geography Research Ethics Commit-
tee, The University of Sheffield, Sheffield (UK), the 
Institutional Review Board of the Institute of Tropical 
Medicine, Antwerp (Belgium) and the of The Gambia 
Government/MRCG Joint Ethics Committee. The inter-
viewers followed the Code of Ethics of the American 
Anthropological Association (AAA). The village leaders 
(Alkalos) and all interviewees were informed before the 
start of the interview about project goals, the topic and 
type of questions as well as their right to decline partici-
pation, to interrupt or withdraw from the conversation 
at any time. Oral informed consent was obtained before 
each interview, which was documented by the researcher. 
Oral consent was favoured since participants were not at 
any particular risk and moreover, within the local com-
munities, the act of signing one’s name on a piece of 
paper was expected to bring about mistrust towards the 
research team [25, 26] as this is not customary practice. 
Anonymity and confidentiality were guaranteed by using 
only descriptive identifiers and assigning a unique code 
number to each informant.
Results
Adherence to anti‑malarial treatment during pregnancy
Mothers in general explained that adherence to anti-
malarial treatment during pregnancy was problematic 
and that pregnant women regularly threw away their 
medication or stored it at home. Adherence to treatment 
would reportedly stop after 1 or 2 days.
“There are a lot of such cases in this area where preg-
nant women throw away the medication or hide it 
behind their pillows.” (TBA, Demba Kunda Kuta)
“You know, for some pregnant women, when they feel 
better after a day or two of taking the medicine, they 
stop and just hide the rest underneath their pillows.” 
(Pregnant woman, Demba Kunda Koto)
Main reasons for these perceptions, as outlined below, 
were: (i) misconceptions on knowledge of MiP; (ii) per-
ceptions of anti-malarial treatment; and, (iii) the influ-
ence of the therapy management group on adherence.
Table 1 Overview of collected data
Participants 
(N = 31)
Interviews 
(N = 31)
Informal 
conversations 
(N = 25)
Participant 
observation 
(N = 26)
Community 
health nurse 
(n = 2)
1 2 4 (health post)
Husbands 
(n = 4)
4 4 4 (homes)
Mothers-in-law 
(n = 5)
5 5 5 (homes)
TBAs (n = 2) 2 2 4 (homes, health 
post)
Women of 
reproductive 
age (n = 15)
15 10 5 (homes, health 
post)
VHW (n = 4) 4 2 4 (health post)
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Knowledge of malaria in pregnancy
Local concepts of uncomplicated malaria
Although often used in daily life, the term ‘malaria’ was 
considered to be a medical doctors’ expression. Depend-
ing on the context and background, the following local 
terms are used to refer to malaria: kajay, sainaabo and 
susula kurango in Mandinka; and samama ntong yea in 
Serahule. While these local translations are not true syn-
onyms of malaria, people often equate malaria to these 
local concepts of illness that refer to general fevers. In 
the case of susula kurango, the term can be translated 
as ‘mosquito sickness’, and as such directly refers to the 
cause of the sickness.
Non‑specificity of symptoms of pregnancy and of malaria
Adherence to treatment was complicated by the lack of 
recognition of malaria symptoms and their similarity 
with symptoms of pregnancy itself. Symptoms of uncom-
plicated MiP mentioned by women included fever, head-
ache, vomiting, lack of appetite, yellow urine, dizziness, 
body aches, anaemia and general weakness. These same 
symptoms were also mentioned as common complaints 
of pregnancy itself and women found it difficult to sepa-
rate uncomplicated malaria from other pregnancy related 
illnesses and complaints.
Prevention of malaria during pregnancy
When asked how to prevent malaria during pregnancy, 
almost all respondents mentioned the use of bed nets. 
Further measures to prevent malaria were mainly related 
to hygiene, e.g., washing hands before eating food, avoid-
ing food that is contaminated by dirt or flies and clean-
ing the environment. Some women would also mention 
Fansidar, referring to IPTp-SP. Most women indicated 
that without treatment the fetus could develop malaria, 
leading to concerns about possible complications, such as 
stillbirths and even maternal death.
Home treatment
Pregnant women sometimes relied on home treatment 
as a first remedy for mild malaria symptoms. A number 
of easily accessible local herbs such as nebadayo, lemon-
aso and kuninding dolo, were used at home at the onset 
of symptoms. These herbs were recommended by older 
women for cleansing the unborn child in the womb and 
relieving general pregnancy discomforts, which report-
edly included kajay, sainaabo, one of the ways of refer-
ring to malaria. The local herbs were taken in the form of 
tea and consumed until women experienced relief from 
their symptoms. Observational data showed that analge-
sics were readily available at markets and pharmacies and 
women indicated that it is common to sponge-dip the 
body in order to reduce body temperature.
Home treatment was common for mild symptoms. 
Where home treatments failed, pregnant women would 
start seeking bio-medical treatment. Additional reasons 
for home treatment were the time required to look for 
financial means to attend the health facility; and avoiding 
the exposure of their pregnancy when women considered 
this not to be appropriate. This was mostly the case for 
adolescents who would keep their pregnancy hidden from 
health workers especially during the early stages due to 
shyness and shame; and additional and undue attention to 
the pregnancy, prompting many to fear for negative influ-
ences (e.g., witchcraft, jinn) on the pregnancy outcome.
In addition, older women (35+) kept their pregnancy 
hidden as going to ANC created a sense of shame if the 
woman is pregnant at the same time as her daughter or 
daughter-in-law. This prompts them to delay exposing 
their pregnancy and consequently not seeking treatment. 
It was also indicated that experienced women considered 
themselves knowledgeable about the treatments for preg-
nancy requiring less visits to health workers.
Knowledge of bio‑medical treatment
Pregnant women looked for biomedical treatment from 
the VHW, the health post or health facility in addition 
to the home treatments. Only a small number of women 
could mention the name of the medication they received 
for malaria, such as chloroquine, paracetamol, nivaquine, 
Coartem®. Most women described the medication as 
a combination of red and yellow capsules, white tablets 
and red tablets. The term malaria boro (malaria medi-
cine) was used to refer to all anti-malarials taken dur-
ing pregnancy. At the local health posts, CHNs provided 
verbal instructions on the dosage of the medications, in 
addition to markings on the plastic bags containing the 
tablets. However, women reported that certain CHNs did 
not provide any information on the name of the drugs, 
the purpose of the medication, potential side effects or 
the need to complete the medication due to insufficient 
time related to their workload or, it was argued, because 
of their perceptions that women with prior pregnancy or 
MiP experience should be knowledgeable about the med-
ication already. Additionally, some women stated not to 
complete their treatment regimen in the following cases: 
(i) when the treatment was considered effective and they 
got ‘cured’ prior to consuming all doses (e.g., usually 
meaning a renewed appetite for food and the ability to do 
household chores); or alternatively (ii) when the medica-
tion was considered ineffective because symptoms per-
sisted Table 2.
Perceived risks of medication
Pregnant women sometimes reported not complet-
ing their treatment due to persisting concerns about 
Page 5 of 7Jaiteh et al. Malar J  (2016) 15:195 
consuming ‘strong’ medication during pregnancy. Strong 
medication was perceived to result in large-sized babies 
and could therefore lead to risky and painful deliveries. 
Consuming “strong” and/or “western” medication would 
also make pregnant women vomit, dizzy and constantly 
tired, which prevented them from carrying out their 
household chores. Interestingly, despite the fact that bit-
ter foods in general were widely avoided especially early 
in the pregnancy as they are perceived to induce miscar-
riage (e.g., the local herb jalafato), the bitterness of bio-
medical anti-malarials seemed to be less of a problem 
due to the trust placed upon the “doctor” (i.e., all nurses 
and doctors working at the health facility) as a provider 
of “safe medications” (Table 3).
Influence of the therapy management group
Though pregnant women who did not take their anti-
malarial treatment were referred to as ignorant and lack-
ing regard for their own health, there was little indication 
of social pressure to address such behavior. While men 
were widely seen to be responsible for the welfare of the 
family, including the health of their wives, they were not 
knowledgeable about the medication for MiP and were 
frequently absent from the household during the preg-
nancy, especially in the Serahuli communities. In most 
households, the older women, especially mothers-in-law, 
were influential in health-related decision-making pro-
cesses. They were considered more knowledgeable about 
pregnancy-related ailments and local herbs for reliev-
ing the symptoms of pregnancy due to their experience 
in the matter. Informants reported that these influential 
family members would often deter pregnant women from 
adhering to anti-malarial treatment, especially when the 
pregnant woman was not recovering as expected from 
the symptoms of MiP.
Discussion
This study documents perceptions on low adherence to 
anti-malarial treatment despite fairly good bio-medical 
knowledge of the prevention and complications of MiP. 
Informants stated that pregnant women would some-
times throw away medication or hide it from health 
workers. These findings are in line with a previous study 
on antenatal, birth and postpartum care in which health 
workers reported difficulties with rural Gambian wom-
en’s adherence to bio-medical treatment [27].
Table 2 Perceived effectiveness of treatment
Quotes Respondent
I: Why do you think pregnant women don’t complete their medication?
You can see for some once they start taking the medication, they feel better and after 
that they won’t complete their medication because they believe they are cured
Adult woman, farmer, Serahuli, Demba Kunda Koto
I: Why do you think pregnant women do not take their medication as recommended?
R: Some of them, if they are sick and they drink in the afternoon and they feel better 
before the evening dose, they stop taking the medication
Adult man, VHW, Serahuli, Demba Kunda Kuta
I: What happened when you drank your anti-malarial medication?
R: When I took that medication, my symptoms became worse and I was shivering so I 
stopped taking the medication
Adult woman, farmer, Serahuli, Demba Kunda Koto
I: Why do you think pregnant women do not take their medication?
R: Some say that it makes them to vomit, some when they take the medication, they 
cannot do their chores, and they will be sitting in one place
Adult woman, food seller, Mandinka, Demba Kunda Mandika
Table 3 Perceived risks of medication
Quotes Respondent
I: When you were taking the anti-malarial, were you fearful that the medication could be harmful to the 
unborn child?
R: This is possible, if you take some medications and they attack you, and are too strong for your 
body, you do think to yourself that if I continue taking this medication something unfortunate 
could happen to me. So it will make you to stop the medication
Adult woman, farmer, Serahuli, Demba Kunda Koto
I: What other reasons can make a pregnant woman to stop taking her medication?
R: For some people, their unborn babies do not like such medication; therefore they have to stop 
taking the medication
Adult woman, farmer, Serahuli, Demba Kunda Koto
I: Do pregnant women normally complain that medication can be harmful to the unborn child?
R: They sometimes complain that the medication can be strong and make the baby to get big. 
Therefore the delivery process will become harder
Adult man, VHW, Serahuli
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For the period of pregnancy, adherence to treatment 
was difficult due to the non-specificity of the symptoms 
of pregnancy and malaria. The diffuseness of symptoms 
made it difficult for pregnant women to distinguish 
between MiP and general pregnancy ailments. Qualita-
tive studies from settings with heterogenous transmission 
dynamics have previously highlighted women experienc-
ing difficulties in recognizing MiP [17, 28]. In addition, 
when attending the health post or receiving treatment 
from the VHWs, a lack of adequate information provided 
on the bio-medical treatment was stated, by women, to 
be problematic. Previous findings on the health sector in 
rural Gambia also noted tendencies of women being ill-
informed about medication by health workers [29, 30]. 
With limited information on anti-malarial treatment, 
especially for adolescent women and older women (35+), 
who did not expose their pregnancy early and had lim-
ited contact with health workers, the use of anti-malarials 
depended on the perceived effectiveness of the medica-
tion. Discontinuation of treatment was commonly stated 
in cases of fast relief or alleviation of symptoms early dur-
ing treatment as this was perceived as treatment efficacy. 
Conversely, and in a seemingly contradictory manner, 
when symptoms persisted after 1–2  days some women 
discontinued treatment since the medication was seen as 
inefficacious.
The perception that the medication was “too strong”, 
potentially resulting in large sized babies that make the 
delivery process difficult and concerns about the side 
effects such as dizziness were additional motives for 
women not adhering to their treatment. An alternative 
strategy to reinforce women’s adherence could be direct 
observed therapy (DOTs) as it is the case for IPTp-SP. 
However such a strategy could be difficult to implement 
especially since the current recommended case manage-
ment with ACT from the second trimester requires a 
3-day course treatment regime. Addressing such strongly 
held beliefs regarding malaria medication during health 
promotion and education at the community level is, 
therefore, important as they have implications for the 
effective case management of MiP.
Women’s existing trust in health workers and the health 
system had a positive influence on the acceptance of the 
medication during pregnancy. In contrast to other stud-
ies in sub-Saharan Africa [17, 31, 32], women generally 
accepted medication from health workers despite the bit-
ter taste. Brabin et al. [16] describe how in 2007 Gambian 
women accepted SP to be safe because health workers 
administered the drugs [16], highlighting women’s trust 
in MRCG and to some extent the larger health system in 
the Gambia.
Finally, women’s decision to adhere to their anti-malar-
ial treatment during pregnancy was influenced by the 
advice given by their mothers-in-law. It is important to 
understand the gender related dynamics of decision-mak-
ing, resource allocation and authority within a household 
as it can have an influence on women’s treatment behav-
iour. The married women settled patrilocally (at the place 
of residence of their husband) in big compounds shared 
with the extended members of their husband’s family. 
Similar to other societies where men are regarded house-
hold heads, the husbands here were described as finan-
cial providers that may make decisions on financial issues 
thereby directly or indirectly influencing women’s health. 
However they were also described as not being knowl-
edgeable about the necessary treatments for pregnancy 
related ailments. In contrast, the mothers-in-laws formed 
a core part of pregnant women’s treatment management 
group. In their role as managing the welfare of their 
daughters-in-law, the mothers-in-law gave advice on the 
recognition, care and treatment of pregnancy related 
ailments. Due to the significant influence on women’s 
decision-making, integrating mothers-in-law in health 
activities targeted at pregnant women could improve 
adherence to treatment since they hold high social status 
and positions in within their households.
The main study limitation was the non-inclusion of 
the views of pregnant women diagnosed with malaria by 
RDT and taking anti-malarial medication at the time of 
the study. This was not feasible within the study period 
due to rapidly declining prevalence of MiP. However, the 
decision not to rely on the accounts of malaria-infected 
pregnant women had the advantage of minimizing social 
desirability bias (i.e., apparent contradictions in adherence 
to treatment due to the tendency to answer questions in a 
manner that will be viewed favourably by others).
Conclusion
Strategies for the control of MiP involving anti-malarial 
treatment will by definition depend on pregnant women’s 
completion of medication. Using standard health edu-
cation and awareness programmes to inform women of 
their risks of MiP and its associated complications are 
not necessarily enough to increase adherence. Struc-
tural barriers such as the type and level of health worker 
communication with women on the importance of the 
completion of treatment, illness recognition and side 
effects of the medication need to be addressed. Addition-
ally, family members such as mothers-in-law should be 
included in community-based programmes for MiP due 
to their significant influence on pregnant women’s health.
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